Grandmoms
Grandmoms
Sex: F
Data Quality: 0 stars
MS: 42 yrs
Type: Relapsing-Remitting
Sensation: Moderate
Overall: Mild
Cognition: moderate
Vision: none
Speech: mild
Swallowing: moderate
Upper limb: mild
Walking: mild
Grandmoms
Female, 70 years
Lebanon, VA
Primary Condition
MS and 1 more
Type
Relapsing-Remitting
First symptom
Jan 1970
Diagnosis
Sep 1993
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

Grandmoms's Copaxone is for:

  • MS

Grandmoms has not reported any side effects for Copaxone.

Grandmoms's Copaxone History (Stopped)
Copaxone (glatiramer acetate)
20 mg Daily Jul 14, 2005 - Oct 20, 2011
Stopped Other Oct 20, 2011
Evaluations
Date Dosage MS (Multiple Sclerosis) Efficacy Side Effects Adherence Burden
Oct 20, 2011 20 mg Daily ? NoneNoneNoneNone AlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at all
Aug 20, 2010 20 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 NoneNoneNoneNone AlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at all
Date
Oct 20, 2011
Advice & Tips
I developed lumps/knots under my skin that may not have been related to the Copaxone. After ultra-sound and MRI, no conclusive diagnoses for the knots. I was so tired of the daily shots and the sudden development of the knots I decided to stop the treatment.
Cost
< $25 monthly
Date
Aug 20, 2010
Advice & Tips
I get tired of taking this shot every day, however, I have had no major flare ups since beginning this medication. Very soon after I began this medication I lost 15 pounds and that was an unexpected benefit. In the beginning and for six or eight months the injection site itched and nearly drove me nuts. I ignored the itching and one day realized the itching had stopped.

About Copaxone (Prescription Drug)

Copaxone®, a brand name of glatiramer acetate, combines four amino acids including L-alanine, L-glutamic acid, L-lysine and L-tyrosine. It is used for Relapsing-Remitting Multiple Sclerosis (RRMS) to reduce the frequency and severity of relapses. It is administered as a subcutaneous injection. Read more...Click to read more below

Learn more about Copaxone in our Copaxone Community Report.